Skip to Content
Stock Strategist

The Market's Most Overvalued Stocks

There are still expensive stocks in real estate.

Mentioned: , , , , , ,

In our previous article on the market's most overvalued stocks, we highlighted large-cap stocks that still appeared expensive, despite our opinion that the overall asset class seemed cheap. For this installment, we chose to focus on real estate. Note that this category does not include homebuilders, but rather is dominated by real estate investment trusts and other financial-services firms that focus on real estate.

Although many companies in this arena appear to be selling at a significant discount to their intrinsic values (16 of the 220 as of this writing,  click here to run this screen), there are still several that trade at a premium. To parse these expensive stocks from the pack, we developed a screen to find real estate firms trading at or below 2 stars with no competitive advantages and average or greater-than-average risk.  The result was seven no-moat, average-risk stocks--all of which are REITs.

Joel Bloomer does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.